Tibulizumab (Anti-BAFF & IL-17)
Tibulizumab (LY3090106) is a tetravalent bispecific antibody which potently inhibits both B cell activating factor (BAFF), also known as CD257 and interleukin-17A (IL-17). It is used for the treatment of autoimmune diseases. MW: 201.44 KD.
| Trivial name | LY3090106 |
| Catalog Number | A4001 |
| CAS# | 1849636-24-3 |
| Size | 1mg |
| Supplier Page | http://www.selleckchem.com/products/tibulizumab.html |